Pulmatrix (PULM)

Pulmatrix (PULM) Income Statement


Pulmatrix Income Statement

Last quarter (Q3 2023), Pulmatrix's total revenue was $1.75M, a decrease of -6.36% from the same quarter last year. In Q3, Pulmatrix's net income was $-3.77M. See Pulmatrix’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 6.80M$ 6.07M$ 5.17M$ 12.63M$ 7.91M$ 153.00K
Cost of Revenue
Gross Profit
$ 6.80M$ 6.07M$ 5.17M---
Operating Expense
$ -590.00K$ 25.02M$ 21.76M$ 22.50M$ 21.33M$ 20.48M
Operating Income
$ -4.67M$ -18.95M$ -16.59M$ -9.86M$ -13.42M$ -20.33M
Net Non Operating Interest Income Expense
$ 675.00K$ 309.00K$ 7.00K$ 82.00K$ 301.00K$ -159.00K
Other Income Expense
$ 280.00K$ 198.00K$ 11.00K$ -9.53M$ -7.47M$ -73.00K
Pretax Income
$ -4.09M$ -18.84M$ -20.17M$ -19.31M$ -20.60M$ -20.56M
Tax Provision
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ -4.09M$ -18.84M$ -23.37M$ -19.31M$ -20.60M$ -20.56M
Basic EPS
$ -5.94$ -5.46-$ -13.40$ -1.23$ -4.98
Diluted EPS
$ -3.29$ -5.46$ -172.60$ -13.40$ -1.23$ -4.98
Basic Average Shares
$ 7.31B$ 3.45M$ 135.43K$ 1.44M$ 16.73M$ 4.13M
Diluted Average Shares
$ 7.31B$ 3.45M$ 135.43K$ 1.44M$ 16.73M$ 4.13M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ -590.00K$ 25.02M$ 21.76M$ 22.50M$ 21.33M$ 20.48M
Net Income From Continuing And Discontinued Operation
$ -16.25M$ -18.84M$ -20.17M$ -19.31M$ -20.60M$ -20.56M
Normalized Income
$ -6.00M--$ -10.02M$ -13.33M$ -20.50M
Interest Expense
----$ 0.00$ 186.00K
$ -4.95M$ -19.14M$ -20.18M$ -9.86M$ -13.42M$ -20.38M
$ -633.00K$ -17.60M$ -20.35M$ -8.82M$ -12.66M$ -20.15M
Currency in USD

Pulmatrix Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis